Insider Trading March 18, 2026

Babcock & Wilcox CEO Increases Stake With $106,015 Market Purchase; Earlier Option Exercise and RSU Grant Expanded Holdings

Kenneth M. Young adds shares through open-market purchases and option exercise as company posts a narrower-than-expected Q4 2025 loss

By Leila Farooq BW
Babcock & Wilcox CEO Increases Stake With $106,015 Market Purchase; Earlier Option Exercise and RSU Grant Expanded Holdings
BW

Kenneth M. Young, chief executive officer of Babcock & Wilcox Enterprises (NYSE: BW), purchased 7,000 shares on March 18, 2026, for $106,015 and earlier exercised options on March 16 to acquire 250,000 shares. The March activity also included a withholding of shares for tax obligations and a grant of 250,000 restricted stock units. The company reported a fourth-quarter 2025 loss per share that was smaller than analysts expected and revenue that topped forecasts.

Key Points

  • CEO Kenneth M. Young purchased 7,000 shares on March 18, 2026, for $106,015 at $15.10-$15.15 per share.
  • On March 16 Young exercised options for 250,000 shares at $10.51 per share, had 119,625 shares withheld for taxes, and received a grant of 250,000 restricted stock units.
  • After these transactions, Young directly owns 1,656,512 shares and indirectly owns 272,767 shares; Babcock & Wilcox reported Q4 2025 results with a $0.05 loss per share and $161 million in revenue, both ahead of forecasts.

Kenneth M. Young, chief executive officer of Babcock & Wilcox Enterprises (NYSE: BW), increased his direct stake in the company through a small open-market purchase on March 18, 2026, and larger option-related transactions two days earlier.

On March 18, Young completed a purchase of 7,000 shares of Babcock & Wilcox common stock. The transactions were executed at prices between $15.10 and $15.15 per share, for a total cash outlay of $106,015.

Prior to that market purchase, on March 16 Young exercised options that resulted in the acquisition of 250,000 shares of common stock at an exercise price of $10.51 per share. The exercise represented a gross value of $2,627,500. Also on March 16, the issuer withheld 119,625 of the newly issued shares to satisfy tax withholding requirements; those withheld shares were valued at $1,257,258 using the same per-share price of $10.51.

In addition to the option exercise and withholding, Young was granted 250,000 restricted stock units on March 16. Following the combination of these recent movements, Young’s direct ownership stands at 1,656,512 shares of Babcock & Wilcox Enterprises. He also retains an indirect holding of 272,767 shares that are held in a revocable trust.


Separately, Babcock & Wilcox reported fourth-quarter 2025 financial results that modestly exceeded analyst expectations. The company recorded a loss per share of $0.05 for the quarter, compared with the consensus forecasted loss of $0.0667. That difference equates to a positive surprise of 25.04% relative to the expected loss.

Revenue for the quarter came in at $161 million, surpassing the anticipated $158.97 million. The reported results were characterized in the company release as outperforming market expectations, a development noted as potentially encouraging to investors and as able to affect future analyst evaluations.

The sequence of option exercise, tax-related withholding, an RSU grant, and a modest open-market purchase together changed the composition of Young’s holdings but left him with a majority of his interest held directly. The company’s quarterly figures, while still showing a loss, demonstrated a narrower shortfall than analysts had projected and slightly higher revenue, according to the published numbers.


Key points

  • Kenneth M. Young bought 7,000 shares on March 18, 2026, for $106,015 at prices between $15.10 and $15.15 per share.
  • On March 16, Young exercised options to acquire 250,000 shares at $10.51 per share, and 119,625 shares were withheld to cover tax obligations; he was also granted 250,000 restricted stock units that day.
  • After these transactions, Young directly owns 1,656,512 shares and indirectly owns 272,767 shares in a revocable trust; the company reported a Q4 2025 loss per share of $0.05 and revenue of $161 million, both ahead of consensus estimates.

Risks and uncertainties

  • The company still reported a net loss per share of $0.05 for Q4 2025 despite the beat versus expectations - the ongoing presence of losses is a financial risk highlighted by the results.
  • Withholding of 119,625 shares to satisfy tax obligations reduced the net new shares retained from the option exercise, which affects immediate share-count changes.
  • Future analyst assessments remain uncertain - while results beat expectations, any subsequent revisions by analysts are not known and could change market perception.

Risks

  • The company reported a loss per share of $0.05 in Q4 2025 despite beating expectations, indicating ongoing losses remain a financial risk.
  • 119,625 shares were withheld by the issuer to cover tax obligations, reducing the net shares retained from the March 16 option exercise.
  • Analyst evaluations could change following these results, and future revisions are uncertain.

More from Insider Trading

Wesbanco Director Kerry Stemler Buys $30,800 in WSBC Stock as Bank Pursues Florida Expansion Mar 18, 2026 Ten-Percent Expensify Holder Adds $2.13 Million in Shares as Stock Trades Near 52-Week Low Mar 18, 2026 Foxx Development CEO Disposes of $30,436 in Stock; Board Addition and Meeting Clarification Also Filed Mar 18, 2026 IRadimed CEO Disposes $762,970 in Stock as Shares Trade Near Yearly Peak Mar 18, 2026 Harvard Bioscience Director Increases Stake with $48,700 Purchase Mar 18, 2026